Kuwait

Health product regulation in Kuwait is overseen by the Kuwait Drug and Food Control Administration (KDFCA), operating under the Ministry of Health (MoH). The primary legislative framework is grounded in Law No. 48 of 1967 on the Practice of Medical Professions and its subsequent amendments, alongside specific ministerial decrees governing pharmaceuticals, medical devices, diagnostics, and digital health products. All health products intended for the Kuwaiti market must undergo a formal registration process administered by the KDFCA, which evaluates safety, efficacy, and quality prior to granting market authorization. Medical devices and diagnostics are additionally subject to classification-based review pathways, with higher-risk products requiring more rigorous technical and clinical documentation.

Applicants are required to appoint a locally registered commercial agent or authorized representative to submit and manage registration dossiers on their behalf. Kuwait generally accepts dossiers prepared according to the International Council for Harmonisation Common Technical Document (ICT-CTD) format, and registration decisions for pharmaceuticals often reference approvals from stringent regulatory authorities such as the US FDA, EMA, or UK MHRA as supporting evidence. Kuwait is a member of the Gulf Health Council (GHC), and the country participates in the GCC Centralized Drug Registration (CDR) program, which allows manufacturers to seek unified registration across multiple Gulf Cooperation Council member states simultaneously, significantly reducing duplication of effort. Recent reforms have focused on accelerating review timelines for priority medicines, introducing expedited pathways for products addressing unmet medical needs, and developing a clearer regulatory framework for digital health and Software as a Medical Device (SaMD) in alignment with evolving GCC-wide guidance.

Public procurement of health products in Kuwait is highly centralized, with the Ministry of Health serving as the dominant purchaser for the public sector. The Central Tenders Committee (CTC), established under Law No. 37 of 1964 and its amendments, governs the formal tendering process for government acquisitions above defined financial thresholds, including pharmaceuticals, medical devices, diagnostics, and health technologies. The MoH issues annual and periodic tenders for its network of public hospitals, primary care centers, and specialty facilities. Products must be registered with the KDFCA prior to eligibility for public procurement, and tenders are typically evaluated on the basis of price, compliance with technical specifications, delivery terms, and local registration status. The Kuwait Oil Company (KOC) and other state-linked entities operate parallel procurement channels for their own healthcare facilities, adding an additional institutional procurement segment outside the core MoH structure.

The private healthcare sector in Kuwait is a growing and commercially significant channel, comprising private hospitals, polyclinics, pharmacies, and diagnostic laboratories that procure health products independently through licensed importers and distributors. Private sector procurement is driven by market demand, clinician preference, and commercial negotiation rather than centralized tendering. Kuwait does not rely meaningfully on donor-funded procurement mechanisms such as UNICEF Supply Division, the Global Fund, USAID, or Gavi, given its high-income country status and self-funded national health system. However, Kuwait does participate in GCC-level group purchasing initiatives coordinated through the Gulf Health Council, which can yield economies of scale for selected essential medicines and health commodities. Local manufacturing of health products remains limited, and while there is no explicit mandatory local manufacturing preference policy enforced in procurement decisions, government policy documents have increasingly signaled an interest in building domestic pharmaceutical manufacturing capacity as part of broader economic diversification efforts aligned with Kuwait Vision 2035.